People with diabetes have a higher risk of developing Alzheimer's disease (AD) raising a possible link between the cells that ...

Telomir announced results from its recent preclinical studies conducted in human cell lines. These studies demonstrated the ability of ...

The human brain is a complex powerhouse, responsible for orchestrating thoughts, emotions, and memories. Its nerve cells ...

A WOMAN who was jailed for stealing £20,000 from an old man with Alzheimer’s has revealed just what it was like in prison.

The company says preclinical trials demonstrate its signature molecule can help prevent cell damage that can lead to ...

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

Telomir Pharmaceuticals (TELO) announceS results from recent preclinical studies demonstrating the ability of Telomir-1 to fully reverse oxidative stress in human cell lines.

One will also target Alzheimer’s—by replacing the brain cells known as microglia—and another is a treatment ... And he’s ...

CU is participating in the nationwide “Guiding an Improved Dementia Experience” Model, a new health care payment and service delivery model that includes family caregiver support.

For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell ...

Wildfire smoke, long recognized as a health threat to the lungs and heart, may also pose significant risks to brain health, ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...